Microbiology Claims With Sources

 Quick Analysis Plan Copied

 Long Analysis Plan

Evidence-Set Mismatch: No Detection/Diagnostic Papers Are Present

The requested topic — review bias and reproducibility of CRISPR-Cas pathogen detection (e.g., SHERLOCK/DETECTR diagnostics) — cannot be answered from these records. All six primary papers concern CRISPR-Cas biology in pathogens (virulence regulation, gene editing, HGT barriers), not diagnostics. Rejecting the premise: any 'detection review audit' claims would be confabulated from these sources.

What the Records Do Support: Reproducibility Scoring Across the Set

Assigned audit scores reveal a consistent pattern — high novelty/quality in mechanistic work, but reproducibility systematically lower than usefulness, driven by single-strain designs and limited raw-data deposition:

Critical Weaknesses Identified

• Single-strain generalization: The Klebsiella Klebsiella I-E* CRISPR virulence study and Acinetobacter Acinetobacter BaeR–H-NS Cas3 regulation studies each use one clinical strain; authors explicitly flag non-generalizability.
• Model limitations: Galleria mellonella lacks adaptive immunity; mouse work in the AB43 study is limited to two in vivo models; Salmonella work is in vitro only, two serovars Salmonella serovar CRISPR stress regulation.
• Small n and observation-only designs: The Mosul survey (n=23 isolates) is cross-sectional, PCR presence/absence without spacer or functional assays — a reproducibility and causal-inference ceiling Mosul CRISPR-Cas clinical survey. Clostridium editing screened only ~10 colonies per construct Clostridium CRISPR editing efficiencies.
• Data transparency gaps: Only the Klebsiella study deposited sequencing data (SRA PRJNA1201895); the A. baumannii and Salmonella papers provide no public accessions — a reproducibility red flag.
• Conflict-of-interest variance: The Clostridium study declares a founder financial interest (Neemo Inc., biofuels); the Mosul paper lists no funding at all — both warrant scrutiny Clostridium paper conflict-of-interest statement.

Battle-Test Verdict and Falsification Path

Confidence: moderate-high that the strongest records (A. baumannii, Clostridium) are internally rigorous but externally constrained to their strain backgrounds. The audit conclusion would change if: (1) replication of casABECD/hut regulation across multiple hvKp lineages failed; (2) larger, multi-region CAS1A–resistance cohorts showed no inverse association; (3) raw data from non-depositing studies, once released, contradicted reported phenotypes. A genuine detection-diagnostics evidence set is required to answer the literal question posed.